David Mathes
Concepts (407)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 42 | 2025 | 104 | 10.860 |
Why?
| | Perforator Flap | 14 | 2025 | 20 | 5.340 |
Why?
| | Surgery, Plastic | 11 | 2025 | 52 | 3.220 |
Why?
| | Vascularized Composite Allotransplantation | 5 | 2024 | 30 | 3.100 |
Why?
| | Surgical Flaps | 12 | 2024 | 142 | 3.020 |
Why?
| | Transplantation Tolerance | 9 | 2024 | 37 | 2.560 |
Why?
| | Graft Survival | 16 | 2024 | 526 | 2.310 |
Why?
| | Graft Rejection | 14 | 2024 | 540 | 2.190 |
Why?
| | Epigastric Arteries | 15 | 2025 | 21 | 2.100 |
Why?
| | Free Tissue Flaps | 7 | 2025 | 45 | 2.080 |
Why?
| | Rectus Abdominis | 5 | 2024 | 16 | 1.820 |
Why?
| | Skin Transplantation | 9 | 2018 | 85 | 1.670 |
Why?
| | Breast Neoplasms | 20 | 2026 | 2447 | 1.640 |
Why?
| | Postoperative Complications | 24 | 2026 | 2916 | 1.610 |
Why?
| | Microsurgery | 10 | 2024 | 72 | 1.590 |
Why?
| | Myocutaneous Flap | 3 | 2024 | 8 | 1.490 |
Why?
| | Composite Tissue Allografts | 4 | 2016 | 8 | 1.470 |
Why?
| | Facial Transplantation | 5 | 2014 | 10 | 1.460 |
Why?
| | Breast Implants | 6 | 2025 | 25 | 1.430 |
Why?
| | Breast Implantation | 5 | 2025 | 16 | 1.320 |
Why?
| | Hand Transplantation | 5 | 2011 | 9 | 1.310 |
Why?
| | Surgical Wound Dehiscence | 4 | 2024 | 19 | 1.130 |
Why?
| | Immune Tolerance | 8 | 2024 | 379 | 1.090 |
Why?
| | Transplantation Chimera | 6 | 2014 | 56 | 1.060 |
Why?
| | Bone Marrow Transplantation | 6 | 2014 | 294 | 1.030 |
Why?
| | Rhinoplasty | 2 | 2026 | 37 | 0.990 |
Why?
| | Mastectomy | 9 | 2026 | 162 | 0.990 |
Why?
| | Acellular Dermis | 3 | 2022 | 9 | 0.980 |
Why?
| | Transplantation, Homologous | 14 | 2016 | 415 | 0.960 |
Why?
| | Fat Necrosis | 2 | 2022 | 10 | 0.890 |
Why?
| | Angiography | 5 | 2022 | 207 | 0.860 |
Why?
| | Craniosynostoses | 4 | 2026 | 68 | 0.850 |
Why?
| | Retrospective Studies | 43 | 2026 | 17009 | 0.840 |
Why?
| | Iliac Artery | 1 | 2024 | 55 | 0.840 |
Why?
| | Abdominal Wall | 3 | 2025 | 27 | 0.830 |
Why?
| | Immunosuppressive Agents | 8 | 2024 | 846 | 0.820 |
Why?
| | Breast | 5 | 2024 | 157 | 0.820 |
Why?
| | Body Dysmorphic Disorders | 1 | 2023 | 10 | 0.810 |
Why?
| | Surgical Wound Infection | 8 | 2025 | 316 | 0.770 |
Why?
| | Immunotoxins | 4 | 2025 | 55 | 0.760 |
Why?
| | Preoperative Care | 5 | 2012 | 379 | 0.750 |
Why?
| | Enoxaparin | 1 | 2023 | 67 | 0.750 |
Why?
| | Venous Thromboembolism | 2 | 2023 | 324 | 0.720 |
Why?
| | Vascular Surgical Procedures | 2 | 2019 | 339 | 0.710 |
Why?
| | Transplant Donor Site | 1 | 2021 | 2 | 0.710 |
Why?
| | Subcutaneous Tissue | 1 | 2021 | 26 | 0.700 |
Why?
| | Humans | 101 | 2026 | 144261 | 0.690 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2016 | 674 | 0.670 |
Why?
| | Pressure Ulcer | 2 | 2011 | 43 | 0.650 |
Why?
| | Cleft Lip | 3 | 2026 | 72 | 0.640 |
Why?
| | Diphtheria Toxin | 4 | 2025 | 65 | 0.580 |
Why?
| | Anticoagulants | 2 | 2023 | 721 | 0.580 |
Why?
| | Tissue Transplantation | 3 | 2012 | 9 | 0.560 |
Why?
| | Kidney Transplantation | 5 | 2012 | 704 | 0.560 |
Why?
| | Female | 62 | 2026 | 77976 | 0.550 |
Why?
| | Nipples | 1 | 2018 | 10 | 0.550 |
Why?
| | Swine | 11 | 2024 | 831 | 0.540 |
Why?
| | Models, Animal | 4 | 2024 | 392 | 0.520 |
Why?
| | Tomography, X-Ray Computed | 4 | 2026 | 2730 | 0.510 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2016 | 27 | 0.500 |
Why?
| | Treatment Outcome | 22 | 2025 | 11643 | 0.500 |
Why?
| | Tissue and Organ Harvesting | 2 | 2014 | 73 | 0.480 |
Why?
| | Middle Aged | 32 | 2026 | 35762 | 0.470 |
Why?
| | Patient Safety | 1 | 2019 | 347 | 0.460 |
Why?
| | Internet | 3 | 2025 | 698 | 0.450 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 320 | 0.450 |
Why?
| | Frontal Bone | 2 | 2025 | 18 | 0.450 |
Why?
| | Reoperation | 6 | 2026 | 629 | 0.440 |
Why?
| | Malpractice | 2 | 2025 | 44 | 0.440 |
Why?
| | Groin | 1 | 2014 | 13 | 0.430 |
Why?
| | Orbit | 2 | 2025 | 64 | 0.430 |
Why?
| | Perineum | 1 | 2014 | 37 | 0.430 |
Why?
| | Practice Patterns, Physicians' | 3 | 2023 | 1347 | 0.420 |
Why?
| | Pregnancy, Animal | 1 | 2014 | 52 | 0.420 |
Why?
| | Bone Transplantation | 3 | 2025 | 85 | 0.420 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2025 | 95 | 0.420 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2014 | 30 | 0.420 |
Why?
| | Negative-Pressure Wound Therapy | 2 | 2024 | 28 | 0.420 |
Why?
| | Patient Satisfaction | 3 | 2024 | 704 | 0.410 |
Why?
| | Interleukin-2 | 4 | 2024 | 437 | 0.410 |
Why?
| | Swine, Miniature | 8 | 2024 | 89 | 0.400 |
Why?
| | Adult | 31 | 2026 | 40262 | 0.400 |
Why?
| | Length of Stay | 6 | 2025 | 1335 | 0.390 |
Why?
| | Pelvis | 1 | 2014 | 124 | 0.390 |
Why?
| | Dogs | 5 | 2016 | 437 | 0.380 |
Why?
| | Facial Injuries | 2 | 2009 | 24 | 0.370 |
Why?
| | Face | 2 | 2013 | 173 | 0.370 |
Why?
| | United States | 20 | 2026 | 15876 | 0.350 |
Why?
| | Prosthesis-Related Infections | 2 | 2024 | 99 | 0.350 |
Why?
| | Lymphoma, T-Cell, Cutaneous | 2 | 2023 | 45 | 0.350 |
Why?
| | Communications Media | 1 | 2011 | 4 | 0.340 |
Why?
| | Surgical Mesh | 2 | 2025 | 50 | 0.340 |
Why?
| | Abdomen | 3 | 2024 | 141 | 0.340 |
Why?
| | Attitude of Health Personnel | 2 | 2009 | 1182 | 0.330 |
Why?
| | Bariatric Surgery | 2 | 2024 | 236 | 0.330 |
Why?
| | Antibiotic Prophylaxis | 1 | 2012 | 129 | 0.330 |
Why?
| | Medicaid | 2 | 2025 | 461 | 0.330 |
Why?
| | Animals | 23 | 2025 | 38030 | 0.320 |
Why?
| | Computed Tomography Angiography | 2 | 2022 | 145 | 0.320 |
Why?
| | Obesity, Morbid | 2 | 2024 | 275 | 0.320 |
Why?
| | Coitus | 1 | 2010 | 23 | 0.310 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2010 | 40 | 0.310 |
Why?
| | Ultrasonography, Doppler | 1 | 2010 | 126 | 0.300 |
Why?
| | Osteomyelitis | 1 | 2011 | 143 | 0.300 |
Why?
| | Body Mass Index | 3 | 2024 | 2420 | 0.300 |
Why?
| | Arteries | 2 | 2013 | 258 | 0.290 |
Why?
| | Amputation, Traumatic | 1 | 2009 | 21 | 0.290 |
Why?
| | Traumatology | 1 | 2009 | 35 | 0.290 |
Why?
| | Hand Injuries | 1 | 2009 | 33 | 0.290 |
Why?
| | Follow-Up Studies | 9 | 2024 | 5389 | 0.290 |
Why?
| | Suture Techniques | 2 | 2024 | 131 | 0.280 |
Why?
| | Magnetic Resonance Angiography | 1 | 2010 | 251 | 0.280 |
Why?
| | Thigh | 1 | 2008 | 47 | 0.270 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2008 | 21 | 0.270 |
Why?
| | Vagina | 1 | 2010 | 201 | 0.270 |
Why?
| | Skin Neoplasms | 3 | 2023 | 847 | 0.260 |
Why?
| | Hypertrophy | 2 | 2024 | 127 | 0.260 |
Why?
| | Intraoperative Complications | 2 | 2025 | 155 | 0.260 |
Why?
| | Sternum | 2 | 2024 | 26 | 0.260 |
Why?
| | Mastectomy, Segmental | 2 | 2017 | 108 | 0.260 |
Why?
| | Sternotomy | 2 | 2024 | 23 | 0.250 |
Why?
| | Back | 1 | 2006 | 12 | 0.250 |
Why?
| | Orthopedics | 1 | 2009 | 167 | 0.240 |
Why?
| | Cannabis | 2 | 2023 | 509 | 0.240 |
Why?
| | Wounds and Injuries | 2 | 2012 | 952 | 0.240 |
Why?
| | Nasal Septum | 1 | 2026 | 30 | 0.240 |
Why?
| | Cephalometry | 1 | 2026 | 30 | 0.230 |
Why?
| | Orthognathic Surgical Procedures | 1 | 2025 | 6 | 0.230 |
Why?
| | Head and Neck Neoplasms | 3 | 2025 | 556 | 0.230 |
Why?
| | Nerve Block | 2 | 2025 | 103 | 0.230 |
Why?
| | Internship and Residency | 3 | 2025 | 1255 | 0.230 |
Why?
| | Scalp | 1 | 2025 | 37 | 0.230 |
Why?
| | Liability, Legal | 1 | 2025 | 43 | 0.230 |
Why?
| | Histocompatibility | 3 | 2014 | 21 | 0.230 |
Why?
| | Facial Paralysis | 1 | 2025 | 23 | 0.220 |
Why?
| | Inflation, Economic | 1 | 2025 | 3 | 0.220 |
Why?
| | Gynecologic Surgical Procedures | 1 | 2025 | 64 | 0.220 |
Why?
| | Iatrogenic Disease | 1 | 2025 | 75 | 0.220 |
Why?
| | Muscular Dystrophy, Facioscapulohumeral | 1 | 2025 | 29 | 0.220 |
Why?
| | CD47 Antigen | 1 | 2025 | 42 | 0.220 |
Why?
| | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 26 | 0.220 |
Why?
| | Implant Capsular Contracture | 1 | 2024 | 4 | 0.220 |
Why?
| | Transplantation Conditioning | 3 | 2016 | 186 | 0.220 |
Why?
| | Health Care Reform | 1 | 2025 | 109 | 0.220 |
Why?
| | Societies, Medical | 1 | 2009 | 886 | 0.210 |
Why?
| | Surgery, Computer-Assisted | 1 | 2025 | 84 | 0.210 |
Why?
| | Fibula | 1 | 2024 | 36 | 0.210 |
Why?
| | Gender Dysphoria | 1 | 2024 | 17 | 0.210 |
Why?
| | Anastomosis, Surgical | 3 | 2020 | 157 | 0.210 |
Why?
| | Physical Therapy Modalities | 2 | 2024 | 332 | 0.210 |
Why?
| | Telemedicine | 2 | 2025 | 940 | 0.210 |
Why?
| | Cleft Palate | 1 | 2025 | 89 | 0.200 |
Why?
| | Publishing | 1 | 2025 | 114 | 0.200 |
Why?
| | Risk Factors | 8 | 2026 | 10699 | 0.200 |
Why?
| | Body Contouring | 1 | 2023 | 7 | 0.200 |
Why?
| | Malocclusion | 1 | 2023 | 21 | 0.200 |
Why?
| | Vitamin D Deficiency | 1 | 2025 | 185 | 0.200 |
Why?
| | Insurance | 1 | 2023 | 13 | 0.200 |
Why?
| | Mandibular Fractures | 1 | 2023 | 14 | 0.200 |
Why?
| | Time-to-Treatment | 1 | 2025 | 240 | 0.200 |
Why?
| | Sezary Syndrome | 1 | 2023 | 45 | 0.200 |
Why?
| | Fetus | 2 | 2005 | 803 | 0.200 |
Why?
| | Skull Fractures | 1 | 2023 | 35 | 0.200 |
Why?
| | Mycosis Fungoides | 1 | 2023 | 62 | 0.190 |
Why?
| | Hindlimb | 2 | 2003 | 131 | 0.190 |
Why?
| | Seroma | 1 | 2022 | 2 | 0.190 |
Why?
| | Male | 23 | 2026 | 72035 | 0.180 |
Why?
| | Extremities | 2 | 2002 | 140 | 0.180 |
Why?
| | Antineoplastic Agents | 2 | 2024 | 2192 | 0.180 |
Why?
| | Weight Loss | 1 | 2008 | 832 | 0.180 |
Why?
| | Time Factors | 7 | 2025 | 7155 | 0.180 |
Why?
| | Incidental Findings | 1 | 2022 | 80 | 0.180 |
Why?
| | Clinical Protocols | 1 | 2023 | 282 | 0.180 |
Why?
| | Educational Measurement | 1 | 2024 | 325 | 0.170 |
Why?
| | Hypotension | 1 | 2022 | 126 | 0.170 |
Why?
| | Quality of Life | 4 | 2025 | 3166 | 0.170 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3857 | 0.170 |
Why?
| | Transplantation, Autologous | 3 | 2024 | 290 | 0.170 |
Why?
| | Proteus vulgaris | 1 | 2000 | 1 | 0.170 |
Why?
| | Mediastinitis | 1 | 2000 | 3 | 0.170 |
Why?
| | Proteus Infections | 1 | 2000 | 5 | 0.170 |
Why?
| | Early Detection of Cancer | 1 | 2026 | 462 | 0.170 |
Why?
| | Analgesics, Opioid | 3 | 2025 | 1131 | 0.170 |
Why?
| | Cyclosporine | 3 | 2016 | 265 | 0.160 |
Why?
| | Imaging, Three-Dimensional | 3 | 2026 | 582 | 0.160 |
Why?
| | Epidermal Growth Factor | 1 | 2021 | 171 | 0.160 |
Why?
| | Patient Education as Topic | 1 | 2025 | 777 | 0.160 |
Why?
| | Motivation | 1 | 2025 | 605 | 0.160 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2014 | 388 | 0.160 |
Why?
| | Risk Assessment | 4 | 2026 | 3637 | 0.160 |
Why?
| | Machine Learning | 1 | 2026 | 585 | 0.150 |
Why?
| | Flow Cytometry | 4 | 2020 | 1172 | 0.150 |
Why?
| | Blood Vessel Prosthesis | 1 | 2000 | 140 | 0.150 |
Why?
| | Databases, Factual | 4 | 2026 | 1484 | 0.150 |
Why?
| | Keloid | 1 | 2019 | 8 | 0.150 |
Why?
| | Dermis | 1 | 2019 | 32 | 0.150 |
Why?
| | Antigens | 2 | 2016 | 347 | 0.150 |
Why?
| | Patient Discharge | 1 | 2025 | 977 | 0.140 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2000 | 139 | 0.140 |
Why?
| | Postoperative Period | 2 | 2023 | 353 | 0.140 |
Why?
| | Biomedical Research | 1 | 2025 | 709 | 0.140 |
Why?
| | Mice, SCID | 3 | 2025 | 369 | 0.140 |
Why?
| | Incidence | 2 | 2023 | 2870 | 0.140 |
Why?
| | Tattooing | 1 | 2018 | 12 | 0.140 |
Why?
| | Fluorouracil | 1 | 2019 | 235 | 0.130 |
Why?
| | Indocyanine Green | 2 | 2022 | 42 | 0.130 |
Why?
| | Chimera | 2 | 2011 | 61 | 0.130 |
Why?
| | Data Collection | 2 | 2011 | 633 | 0.130 |
Why?
| | Health Services Accessibility | 1 | 2025 | 1091 | 0.130 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2017 | 88 | 0.130 |
Why?
| | Graft vs Host Disease | 2 | 2016 | 264 | 0.130 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2016 | 89 | 0.120 |
Why?
| | Hernia, Ventral | 1 | 2016 | 22 | 0.120 |
Why?
| | Bupivacaine | 1 | 2016 | 38 | 0.120 |
Why?
| | Mycophenolic Acid | 1 | 2016 | 120 | 0.120 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 6021 | 0.120 |
Why?
| | Herniorrhaphy | 1 | 2016 | 74 | 0.120 |
Why?
| | Aged | 9 | 2025 | 25850 | 0.110 |
Why?
| | Prospective Studies | 3 | 2021 | 7970 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2023 | 576 | 0.110 |
Why?
| | Mental Disorders | 1 | 2024 | 1138 | 0.110 |
Why?
| | Leukocytes | 1 | 2016 | 295 | 0.110 |
Why?
| | Muscle, Skeletal | 2 | 2006 | 1792 | 0.110 |
Why?
| | Whole-Body Irradiation | 2 | 2012 | 76 | 0.110 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 2014 | 51 | 0.110 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2025 | 928 | 0.110 |
Why?
| | Myeloablative Agonists | 1 | 2014 | 23 | 0.110 |
Why?
| | Cadaver | 2 | 2010 | 304 | 0.110 |
Why?
| | False Negative Reactions | 1 | 2014 | 60 | 0.100 |
Why?
| | Multivariate Analysis | 3 | 2016 | 1533 | 0.100 |
Why?
| | Infant | 5 | 2026 | 10022 | 0.100 |
Why?
| | CD3 Complex | 1 | 2014 | 111 | 0.100 |
Why?
| | Patient Selection | 2 | 2008 | 719 | 0.100 |
Why?
| | Temporal Arteries | 1 | 2014 | 43 | 0.100 |
Why?
| | False Positive Reactions | 1 | 2014 | 121 | 0.100 |
Why?
| | Dissection | 1 | 2014 | 56 | 0.100 |
Why?
| | Histocompatibility Antigens | 1 | 2014 | 102 | 0.100 |
Why?
| | Endrin | 2 | 2023 | 11 | 0.100 |
Why?
| | Allografts | 1 | 2014 | 150 | 0.100 |
Why?
| | Random Allocation | 1 | 2014 | 363 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1906 | 0.100 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 202 | 0.100 |
Why?
| | Prosthesis Failure | 1 | 2014 | 125 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.090 |
Why?
| | Prostheses and Implants | 1 | 2014 | 141 | 0.090 |
Why?
| | Health Care Costs | 1 | 2016 | 421 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3403 | 0.090 |
Why?
| | Receptors, CCR4 | 2 | 2024 | 23 | 0.090 |
Why?
| | Pain Management | 1 | 2016 | 405 | 0.090 |
Why?
| | Recurrence | 2 | 2019 | 1134 | 0.090 |
Why?
| | Monitoring, Physiologic | 1 | 2014 | 289 | 0.090 |
Why?
| | Regional Blood Flow | 1 | 2014 | 512 | 0.090 |
Why?
| | Paternalism | 1 | 2011 | 4 | 0.090 |
Why?
| | Beneficence | 1 | 2011 | 20 | 0.090 |
Why?
| | Collagen | 1 | 2014 | 455 | 0.090 |
Why?
| | Marketing of Health Services | 1 | 2011 | 15 | 0.090 |
Why?
| | Hematopoiesis | 1 | 2012 | 194 | 0.090 |
Why?
| | Mice, Inbred NOD | 2 | 2025 | 610 | 0.080 |
Why?
| | Personal Autonomy | 1 | 2011 | 57 | 0.080 |
Why?
| | Intraoperative Care | 1 | 2011 | 62 | 0.080 |
Why?
| | Mice | 6 | 2025 | 18329 | 0.080 |
Why?
| | Professional Practice | 1 | 2011 | 57 | 0.080 |
Why?
| | Ethics, Medical | 1 | 2011 | 86 | 0.080 |
Why?
| | Antibodies, Monoclonal | 3 | 2024 | 1519 | 0.080 |
Why?
| | Child | 6 | 2025 | 22537 | 0.080 |
Why?
| | Treatment Failure | 1 | 2012 | 363 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2025 | 3539 | 0.080 |
Why?
| | Neovascularization, Physiologic | 1 | 2011 | 194 | 0.080 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2010 | 37 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2014 | 4556 | 0.080 |
Why?
| | Nutrition Assessment | 1 | 2010 | 92 | 0.080 |
Why?
| | Informed Consent | 1 | 2011 | 198 | 0.080 |
Why?
| | Radiography, Abdominal | 1 | 2010 | 44 | 0.080 |
Why?
| | Logistic Models | 2 | 2016 | 2104 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1983 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1559 | 0.070 |
Why?
| | Organ Transplantation | 1 | 2011 | 247 | 0.070 |
Why?
| | North America | 1 | 2009 | 310 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 674 | 0.070 |
Why?
| | Young Adult | 5 | 2026 | 13990 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2011 | 729 | 0.070 |
Why?
| | Health Care Surveys | 1 | 2009 | 538 | 0.060 |
Why?
| | Adolescent | 5 | 2026 | 22281 | 0.060 |
Why?
| | Diagnostic Imaging | 1 | 2009 | 338 | 0.060 |
Why?
| | Back Injuries | 1 | 2006 | 5 | 0.060 |
Why?
| | Omentum | 1 | 2006 | 9 | 0.060 |
Why?
| | Wound Healing | 2 | 2023 | 351 | 0.060 |
Why?
| | Spinal Cord Injuries | 1 | 2010 | 240 | 0.060 |
Why?
| | Cytokines | 1 | 2014 | 2061 | 0.060 |
Why?
| | Linear Models | 1 | 2008 | 850 | 0.060 |
Why?
| | Case Management | 1 | 2006 | 66 | 0.060 |
Why?
| | Debridement | 1 | 2006 | 86 | 0.060 |
Why?
| | Photogrammetry | 1 | 2026 | 12 | 0.060 |
Why?
| | Insurance, Liability | 1 | 2025 | 8 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2008 | 1304 | 0.060 |
Why?
| | Child, Preschool | 3 | 2025 | 11774 | 0.060 |
Why?
| | Current Procedural Terminology | 1 | 2025 | 19 | 0.060 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2012 | 1137 | 0.060 |
Why?
| | Melanoma | 1 | 2012 | 760 | 0.050 |
Why?
| | Major Histocompatibility Complex | 1 | 2005 | 229 | 0.050 |
Why?
| | Craniotomy | 1 | 2025 | 82 | 0.050 |
Why?
| | Silicone Gels | 1 | 2024 | 4 | 0.050 |
Why?
| | Operative Time | 1 | 2025 | 175 | 0.050 |
Why?
| | Licensure, Medical | 1 | 2024 | 18 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2111 | 0.050 |
Why?
| | Proof of Concept Study | 1 | 2024 | 85 | 0.050 |
Why?
| | School Admission Criteria | 1 | 2024 | 34 | 0.050 |
Why?
| | Esthetics | 1 | 2024 | 41 | 0.050 |
Why?
| | Pectoralis Muscles | 1 | 2024 | 17 | 0.050 |
Why?
| | Burns | 1 | 2009 | 376 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1047 | 0.050 |
Why?
| | Comprehension | 1 | 2025 | 179 | 0.050 |
Why?
| | Hydrocodone | 1 | 2023 | 17 | 0.050 |
Why?
| | Age of Onset | 1 | 2025 | 536 | 0.050 |
Why?
| | Personnel Selection | 1 | 2024 | 93 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2025 | 6424 | 0.050 |
Why?
| | Tobacco Use | 1 | 2023 | 61 | 0.050 |
Why?
| | Mandible | 1 | 2023 | 72 | 0.050 |
Why?
| | Chemoprevention | 1 | 2023 | 90 | 0.050 |
Why?
| | Pain Measurement | 1 | 2025 | 552 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4254 | 0.050 |
Why?
| | Transgender Persons | 1 | 2026 | 190 | 0.050 |
Why?
| | Electromyography | 1 | 2025 | 415 | 0.050 |
Why?
| | Tissue Donors | 1 | 2005 | 424 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2024 | 238 | 0.050 |
Why?
| | Physicians | 1 | 2011 | 938 | 0.050 |
Why?
| | Umbilicus | 1 | 2022 | 17 | 0.050 |
Why?
| | Genetic Testing | 1 | 2025 | 478 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5813 | 0.050 |
Why?
| | Transplantation Immunology | 1 | 2002 | 29 | 0.050 |
Why?
| | Vitamin D | 1 | 2025 | 399 | 0.040 |
Why?
| | Peripheral Nerves | 1 | 2002 | 72 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2025 | 8243 | 0.040 |
Why?
| | Perfusion | 1 | 2022 | 250 | 0.040 |
Why?
| | Pregnancy | 1 | 2014 | 7180 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 487 | 0.040 |
Why?
| | Cicatrix | 1 | 2022 | 69 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2024 | 573 | 0.040 |
Why?
| | Erlotinib Hydrochloride | 1 | 2021 | 72 | 0.040 |
Why?
| | Povidone-Iodine | 1 | 2000 | 11 | 0.040 |
Why?
| | Insurance, Health | 1 | 2023 | 301 | 0.040 |
Why?
| | Musculoskeletal System | 1 | 2001 | 49 | 0.040 |
Why?
| | Lymphocyte Depletion | 1 | 2001 | 132 | 0.040 |
Why?
| | Therapeutic Irrigation | 1 | 2000 | 69 | 0.040 |
Why?
| | Inhibitory Concentration 50 | 1 | 2020 | 91 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 80 | 0.040 |
Why?
| | Histocompatibility Testing | 1 | 2000 | 121 | 0.040 |
Why?
| | Outpatients | 1 | 2023 | 439 | 0.040 |
Why?
| | Students, Medical | 1 | 2024 | 373 | 0.040 |
Why?
| | Dopamine | 1 | 2022 | 283 | 0.040 |
Why?
| | Patient Readmission | 1 | 2025 | 756 | 0.040 |
Why?
| | Forelimb | 1 | 1999 | 39 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2022 | 627 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2025 | 847 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 557 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 2019 | 36 | 0.040 |
Why?
| | Immunity, Cellular | 1 | 2001 | 272 | 0.040 |
Why?
| | Lymphocytes | 1 | 2001 | 382 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2019 | 115 | 0.040 |
Why?
| | Tacrolimus | 1 | 1999 | 196 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 732 | 0.030 |
Why?
| | Medicare | 1 | 2024 | 881 | 0.030 |
Why?
| | Veterans | 1 | 2010 | 1600 | 0.030 |
Why?
| | Skin | 1 | 2003 | 754 | 0.030 |
Why?
| | Margins of Excision | 1 | 2017 | 51 | 0.030 |
Why?
| | Carcinoma, Lobular | 1 | 2017 | 56 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2020 | 1367 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2019 | 343 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2023 | 878 | 0.030 |
Why?
| | Obesity | 2 | 2024 | 3057 | 0.030 |
Why?
| | Narcotics | 1 | 2016 | 55 | 0.030 |
Why?
| | Cost Savings | 1 | 2016 | 86 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 427 | 0.030 |
Why?
| | Anesthetics, Local | 1 | 2016 | 100 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1075 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 488 | 0.030 |
Why?
| | Rats | 1 | 2024 | 5592 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 335 | 0.030 |
Why?
| | Tissue Expansion Devices | 1 | 2014 | 4 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 968 | 0.030 |
Why?
| | Tissue Expansion | 1 | 2014 | 9 | 0.030 |
Why?
| | Cellulitis | 1 | 2014 | 53 | 0.030 |
Why?
| | Models, Statistical | 1 | 2018 | 677 | 0.030 |
Why?
| | Equipment Failure Analysis | 1 | 2014 | 128 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 5935 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 623 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2017 | 586 | 0.020 |
Why?
| | Leukocyte Transfusion | 1 | 2012 | 5 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1782 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 202 | 0.020 |
Why?
| | Fluorescence | 1 | 2011 | 161 | 0.020 |
Why?
| | Transcription Factors | 1 | 2019 | 1739 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2516 | 0.020 |
Why?
| | Burns, Electric | 1 | 2009 | 26 | 0.020 |
Why?
| | Equipment Design | 1 | 2011 | 530 | 0.020 |
Why?
| | Neurofibromatosis 1 | 1 | 2009 | 54 | 0.020 |
Why?
| | Comorbidity | 1 | 2014 | 1646 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2013 | 1087 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4562 | 0.020 |
Why?
| | Smoking | 1 | 2014 | 1468 | 0.020 |
Why?
| | Wounds, Gunshot | 1 | 2009 | 258 | 0.010 |
Why?
| | Recovery of Function | 1 | 2009 | 706 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 1092 | 0.010 |
Why?
| | Coculture Techniques | 1 | 2004 | 246 | 0.010 |
Why?
| | Antigens, Surface | 1 | 2001 | 157 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4146 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1982 | 0.010 |
Why?
|
|
Mathes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|